Azerbaijan vs Macau, China: New cases tested for RR-/MDR-TB
Azerbaijan
99.0%
in 2024
Macau, China
98.0%
in 2024
Azerbaijan rank
50th
Macau, China rank
53rd
New cases tested for RR-/MDR-TB over time
- Azerbaijan
- Macau, China
How they compare
Azerbaijan currently reports 99.0% against 98.0% in Macau, China, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2005 it was Macau, China ahead.
Azerbaijan ranks 50th and Macau, China ranks 53rd of 192 countries.
Macau, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 96.3% | 72.0% | Macau, China |
| 2010s | 71.5% | 97.9% | 26.4% | Macau, China |
| 2020s | 97.2% | 98.2% | 1.0% | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Azerbaijan or Macau, China?
- Azerbaijan, at 99.0% against 98.0% in Macau, China as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Azerbaijan and Macau, China?
- 1.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Macau, China?
- 18 years are reported by both, from 2005 to 2024.
- How do Azerbaijan and Macau, China rank globally for new cases tested for rr-/mdr-tb?
- Azerbaijan ranks 50th and Macau, China ranks 53rd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.